Hyderabad-based contract research company GVK Biosciences (GVK Bio) has commissioned its clinical pharmacology unit (CPU) in Ahmedabad. The new CPU adds 110 beds to the company's existing capacity of 144 beds. It will conduct a variety of studies in healthy volunteers.
“The opening of the new GVK BIO clinical pharmacology unit reflects our commitment to offer faster recruitment solutions to our customers. The facility has been audited by the DCGI and we have initiated our first study at the Ahmedabad facility,” GVK Bio president, Manni Kantipudi, stated in a press release.
Kantipudi said the key features of the unit included access to special population like young women, post-menopausal women, diseased population and access to about 12,000 healthy volunteers. The facility would also give access to diseased population in the fields of psychiatry, metabolism, cardiovascular and neurology.